Ro’s disruptive telemedicine platform.

Empowering patients with a convenient and confidential online medical services.

About the founders 👤

Zachariah Reitano, who serves as the CEO of Ro, played a pivotal role in the company's founding. His personal experience with health issues and challenges in accessing appropriate care inspired him to create a more accessible and patient-centric healthcare solution. Reitano openly shared his own struggles with erectile dysfunction as a side effect of his heart medication, which helped destigmatize the condition and encouraged others to seek help. His determination to improve the healthcare experience led him to collaborate with Rahmanian and Schutz in establishing Ro.

Saman Rahmanian, the co-founder and Chief Product Officer, brings his expertise in technology and user experience to the table. With a background in software engineering and design, Rahmanian focuses on creating a seamless and user-friendly digital platform for patients to access medical services. His vision is to leverage technology to enhance patient care and bridge the gap between healthcare providers and individuals seeking treatment.

Rob Schutz, the co-founder and Chief Growth Officer, brings a wealth of experience in business development and strategy to Ro. He is responsible for driving the company's growth and expanding its reach. Schutz's strategic insights and industry knowledge have played a crucial role in Ro's rapid expansion and success in attracting investments.

Discovering a golden opportunity 💡

Reitano’s personal experience with health issues and challenges in accessing appropriate care inspired him to create a more accessible and patient-centric healthcare solution.

Welcome to Ro 🏪

Ro is a digital healthcare startup based in the United States. Founded in 2017, Ro aims to provide accessible and affordable healthcare services to patients through its online platform. The company initially focused on men's health and offered treatments for conditions such as erectile dysfunction, hair loss, and skincare. However, it has since expanded its services to include women's health, smoking cessation, weight management, and general primary care.

Ro's platform allows patients to connect with healthcare professionals through telemedicine consultations. Users can schedule online appointments, discuss their symptoms and medical history, and receive personalized treatment plans. Prescriptions can be conveniently delivered to their doorstep through Ro's own pharmacy or partnering pharmacies.

One of Ro's key features is its emphasis on discretion and privacy. The platform provides a secure and confidential environment for patients to discuss sensitive health issues, and all medication packaging is discreetly labeled for privacy.

How profitable is Cita 💵 ?

Ro provides customers with a range of pricing options tailored to their specific healthcare needs. For a convenient monthly mail-order prescription package, customers can subscribe for just $5 per month. Virtual doctor's visits are available for $15, ensuring accessible and affordable healthcare from the comfort of home. For those seeking comprehensive care, including virtual visits, in-home diagnostics, and pharmacy services, Ro offers membership plans ranging from approximately $20 to $40 per month. These flexible pricing options cater to different healthcare requirements, empowering individuals to choose the services that best fit their needs and budget.

What is the growth potential of this business 🌎?

Ro exhibits strong growth potential in the evolving healthcare landscape. The increasing demand for telemedicine, accelerated by the COVID-19 pandemic, creates a favorable environment for Ro's virtual healthcare platform. As telemedicine becomes more widely accepted, Ro is well-positioned to capitalize on the growing preference for convenient and remote healthcare services. Moreover, Ro has the opportunity to expand its services beyond its initial focus on men's health, tapping into a broader range of medical conditions and healthcare needs. By targeting underserved markets and offering affordable flat fees, Ro can reach individuals who are underinsured or face barriers to accessing quality healthcare. Additionally, as digital health awareness continues to rise, Ro can benefit from the general population's growing acceptance and adoption of digital health solutions. The company's ability to innovate and form strategic partnerships with other healthcare providers, pharmacies, and technology companies further strengthens its growth potential, enabling the delivery of enhanced services and expanding its customer base.

Where are they in the funding process💱?

Ro has raised $1 billion dollars so far over seven rounds with the latest one being a series D. Ro's series D funding round, which raised $500 million, was spearheaded by General Catalyst, FirstMark Capital, and TQ Ventures, all of whom are existing investors in the company. This significant investment showcases the continued confidence and support of Ro's current investors in the company's growth trajectory and its ability to disrupt the healthcare industry. The company is now valued at $7 billion.

🐦 @Ro